CLINICAL_TRIALS
ClinicalTrials.gov record update
Managed Access Programs for INC424, Ruxolitinib
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04745637
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:58.241388+00:00
- Published At
- 2025-11-18T00:00:00+00:00
- Record Updated At
- 2025-11-18
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Primary Myelofibrosis (PMF)", "Post Polycythemia Myelofibrosis (PPV MF)", "Thrombocythemia Myelofibrosis (PET-MF)", "Severe/Very Severe COVID-19 Illness", "Polycythemia Vera (PV)", "Steroid Refractory Acute Graft Versus Host Disease (SR aGVHD)", "Steroid Refractory Chronic Graft Versus Host Disease (SR cGVHD)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-18"- protocolSection.identificationModule.nctId
"NCT04745637"- protocolSection.identificationModule.officialTitle
"Managed Access Programs for INC424, Ruxolitinib"- protocolSection.statusModule.overallStatus
"AVAILABLE"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.